Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris: Laval, Quebec Saturday, April 12, 2025, 10:00 Hrs [IST] Bausch Hea ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Sjogren's syndrome usually occurs in women in their 50s and 60s. According to the 2023 data, 15,818 patients, or more than ...

BRIUMVI is indicated for the treatment of adults with relapsing forms of multiple ... nausea, throat irritation, erythema, and an anaphylactic reaction. In MS clinical trials, the incidence of ...

BRIUMVI is indicated for the treatment of adults with relapsing forms of multiple ... nausea, throat irritation, erythema, and an anaphylactic reaction. In MS clinical trials, the incidence of ...

In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of patients and usually presents as erythema, pruritus ...

IN THE NEWS: With a scary outbreak of measles in various parts of the country, it is not reassuring that Secretary of Health and Human Services Robert F. Kennedy Jr. seems to believe vaccinations ...

Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

GSK plc (LSE/NYSE: GSK) today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to recommend use of PENMENVY ...